Home
/
College of Biomedical Science
/
Faculty and Staff
/
Department of Clinical Science and Medical Education Faculty
/
Hennekens, Charles H. Dr.
Printable Version
- University of Pennsylvania, Wharton School of Finance and Commerce, 1959-1960
- B.S., Queens College, Magna cum laude, 1963
- M.D., Cornell University Medical College, 1967
- M.P.H., Harvard School of Public Health, 1972
- M.S., Harvard School of Public Health (Epidemiology)1973
- Dr.P.H., Harvard School of Public Health (Epidemiology), 1975
- D.Sc., University of Medicine and Dentistry of New Jersey, honoris causa, 1996
- D.Sc., Queens College, The City University of New York, honoris causa, 1997
- Intern in Medicine, The New York Hospital-Cornell Medical Center, New York, NY, 1967-1968
- Resident, Internal Medicine, The New York Hospital-Cornell Medical Center, New York, NY, 1968-1969
- Epidemic Intelligence Service (EIS) Officer, Lieutenant Commander, United States Public Health Service, assigned to the Dade County Department of Public Health, Miami, FL, 1969-1971
- Postdoctoral Fellowship in Epidemiology, Harvard School of Public Health, Boston, MA, 1971-1975
Postdoctoral Training:
Dr. Hennekens is the author/co-author of 805 publications including 591 original reports, 211 reviews and
book chapters, and 3 textbooks. Here we show only since year 2004.
- Williams A, Hennekens CH. The role of aspirin in cardiovascular diseases: Forgotten benefits. Expert Opin Pharmacother 2004; 5:109-115.
- Hennekens CH. The ALLHAT-LLT and ASCOT-LLA trials: Are the discrepancies more apparent than real? Cur Ather Rep, 2004; 6:9-12.
- Hennekens, CH. Aspirin: the need for wider utilization in the treatment and prevention of cardiovascular disease in patients with rheumatoid arthritis. In: Gastric Protection in NSAID Therapy. Red Bank, NJ: Fallon Medica; 2004.
- Hussein, SA, Hennekens CH, Lamas GA. An update on clinical trials in pacing: Is dual chamber pacing better? Curr Opin Cardiol. 2004 Jan;19(1):12-8.
- Casey DE, Haupt DW, Newcomer JW, Henderson DC, Sernyak MJ, Davidson M, Lindenmayer JP, Manoukian SV, Banerji MA, Lebovitz HE, Hennekens CH. Anti-psychotic drug associated weight gain and metabolic abnormalities: implications for increased mortality from schizophrenia. J Clin Psych, 2004; 65 Suppl 7:4-18.
- Splaver A, Lamas GA, Hennekens CH. Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology and the need for randomized trials. Am Heart J, 2004; 148(1):34-40.
- Shields M, Hennekens CH. Management of metabolic syndrome: aspirin. In Grundy S (Ed), Endocrinol Metab Clin N Am. 2004; 33:577-93.
- Novela C, Hennekens CH. Hypothesis: Atorvastatin has unique pleiotropic effects leading to early clinical benefits. J Cardiovasc Pharm & Ther, 2004; 9(1): 61-63.
- Hennekens CH, Kanatterud G, Pfeffer M. Aspirin therapy for diabetes mellitus: clinical and research challenges. Diabetes Care, 2004;27(11):2752-4.
- Hennekens CH, Schror K, Weisman S, FitzGerald G. Terms and conditions: semantic complexity and aspirin resistance. Circ, 2004; 110:1706-1708.
- Hennekens CH, Hollar D, Agatston AS. Aspirin and statins to decrease risks of cardiovascular disease: The need for wider utilization. Business Briefing: US Cardiology, 2004:43-44.
- Kurth T, Henneknes CH, Buring JE, Gaziano JM. Apsirin, NSAIDs, and COS-2 inhibitors in cardiovascular disease: possible interactions and implications for treatment of rheumatoid arthritis. Curr Rheum Rpts, 2004;6(5):351-366.
- Pocock S, Wang D, Wilhelmson L, Hennekens CH. The data monitoring experience in CHARM. In: Friedman L, Furberg C, and DeMets D. Data Monitoring in Clinical Trials. 2005, Case11:166-179, Springer, NY
- DeMets D, Hennekens CH. The Physicians’ Health Study: Issues in the Early Termination of the Aspirin Component. In: Friedman L, Furberg C, and DeMets D. Data Monitoring. In Clinical Trials: A Case Studies Approach. 2005, Case3:73-85, Springer,NY .
- Hollar, D Hennekens CH. Antioxidant vitamins and cardiovascular disease: Randomized trials fail to fulfill the promises of observational epidemiology. In: Tardiff JC, Bourassa MG (eds). Antioxidants and Cardiovascular Disease. Dordrecht, The Netherlands: Kluwer Academic Publishers, 2005; 305-327, Springer, NY
- Levine RS, Briggs NC, Hussani DA, Hennekens CH. Health disparities by race: geographic studies of black:white and other racial differences. Chapter 29 in Satcher D and Pamies R (Eds). Multicultural Medicine and Health Disparity, 2005, McGraw-Hill,NY.
- Stier B, Hennekens CH. Phenylpropanolomine and hemorrhagic stroke in the Hemorrhagic Stroke Project: A reappraisal in the context of science, the Food and Drug Administration, and the law. Ann Epidemiol, 2005;16:49-52.
- Hennekens CH, Hennekens A, Hollar, D, Casey DE. Schizophrenia and increased risk of cardiovascular disease. AHJ, 2005;150:1115-1121.
- Bowman TS, Hennekens, CH. Cigarette Smoking and Cessation. In: Gaziano JM (ed). Atlas of Cardiovascular Risk Factors. (first edition). Philadelphia, PA: Current Medicine, 2005,
- Cryer B, Hennekens CH, Hochberg M, Katz PO Changing the Patterns of Coxibs andNSAIDs Prescribing: Balancing CV and GI Risks. Medscape Clinical Update February 17, 2006. Available at: http//www.medscape.com/viewprogram/5060
- Williams RA, Gavin JR, Phillips RA, Sumner AE, Duncan AK, Hollar D, Hennekens CH. High-risk African-Americans with multiple risk factors: Challenges in prevention, diagnosis, and treatment. Ethnicity and Disease, 2006;16:633-639.
- Gorelick P, Sechenova O, Hennekens CH: Evolving perspectives on clopidogrel in the treatment of ischemic stroke. JCPT, 2006;4:245-248
- Serebruany V, Hennekens CH: Hypothesis: Antiplatelet effects of selective serotonin reuptake inhibitors cause clinical benefits on cardiovascular disease and increase risks of bleeding. J Cardiovasc Pharm & Thera, 2006;10:63-64.
- Hennekens CH, Kowalczykowski M, Hollar D: Lack of deleterious interaction between angiotensin receptor blockers and beta-blockers in the treatment of patients with heart failure JCPT, 2006;2:1-3
- Hennekens CH, Hollar D, Eidelman RS, Agatston AS. Recent randomized clinical trials of statins and the revised National Cholesterol Education Guidelines: Implications for Primary Healthcare Providers. MedGenMed, 2006; 8:54-56.
- Hennekens, CH, Sechenova O, Hollar D, Serebruany V: Dose of aspirin in the treatment and prevention of cardiovascular disease; current and future directions. J Cardiovasc Pharm and Ther. 2006, 11(3):1-7.
- Williams RA, Flack J, Gavin J, Schneider W, Hennekens CH: Guidelines for the Management of High Risk African-Americans with Multiple Cardiovascular Risk Factors: Recommendations from an Expert Consensus Panel, Ethnicity and Disease, 2007;17:210-217.
- Gao R, Hennekens CH. Treatment and Prevention of Cardiovascular Disease: The need for wider and appropriate utilization of aspirin in China. Chinese Journal of Internal Medicine 2007;27:78-81
- Hennekens CH; Aspirin in the Secondary and Primary Prevention of Cardiovascular Disease in Medicina Clinica: Aspirin and cardiovascular disease in the XXI Century. Bueno H (ed), 2007, in press.
- Hennekens CH: Clinical Benefiits of Aspirin and Statins on Cardiovascular Disease Individually and In Combination , in Libby P (ed) Proceedings of the Inflammation, Atherosclerosis and Aspirin Summit Meeting, 2007, Inflammation, Atherosclerosis, and Aspirin: New Insights, Libby P., Knappertz V (eds)
- Carillo-Jimenez R,Borzak S, Sechenova O, Hennekens CH: Brain Naturiuretic Peptide: Clinical and Research Challenges JCPT, 2007, in press
- Hennekens CH, Schneider W, Barice EJ: Childhood Obesity: General Considerations, Ped Res, 2007, 61(6):634-635.
- Hennekens CH: Aspirin in the treatment and prevention of cardiovascular disease: current perspectives and future directions. Current Athero Reports, 2007, 9(5):409-416.
- Hennekens CH: Combined pravastatin and acetylsalicylic acid therapy: additive benefits in the management of coronary patients. Am J Cardiovasc Drugs, 2007, 7: 9-11.
- Hennekens CH: Metabolic Syndrome as a co-morbidity in schizophrenia, CMAJ, 2008, in press
- Kilbourne B, Hennekens CH: African-Americans and Coronary Heart Disease: Psychosocial comorbidities in The African-American Handbook of Health, 2008, in press.
- Serebruany V, Malinin A, Hennekens CH: Statins may increase the risk of hemorrhagic stroke. Cerebrovasc. Dis 2007.24:477-479.
- Newcomer JW, Hennekens CH: Major mental illness and premature morbidity and mortality from cardiovascular disease: the need for new paradigms, JAMA, 2007, 298:1794-1796.
- Levine RS, Briggs NC, Hollar D, Husaini BA, Hennekens CH, Kilbourne BJ. Descriptive and analytic epidemiologic studies to identify modifiable determinants of disparities in mortality rates between Blacks and Whites. Ethnicity and Disease, 2007 Spring;17(2):280-3.
- Hennekens CH: Fixed-dose drug combinations of statins: Strengths, limitations, general and specific regulatory considerations. Am J Cardiovasc Drugs, 2008, 8:155-160.
- Hennekens CH, Borzak S: Cyclooxygenase 2 Inhibitors and most traditional nonsteroidal anti-inflammatory drugs produce similar moderately increased risks of cardiovascular disease; JCPT, 2008 Mar; 13(1):41-50.
- Fleischacker WW, Cetkovic-Bakmas M, DeHert M, Hennekens CH, Lambert M, Leucht S, Maj M, McIntyre RS, Naber D, Newcomer J, Olfson M, Osby U, Sartorius N, Lieberman J: Medical comorbidities in patients with severe mental illness: Clinical, policy and research challenges, J Clin Psych, 2008, in press
- Hennekens CH, Schneider WR: Statins and Aspirin Produce Additive Benefits in the Treatment of Cardiovascular Disease, Expert Review of Cardiovascular Therapy, 2008, 6(1): 95-107.
- Hennekens CH: Foreword to The Great American Heart Hoax. Ozner M. Benbella Books, Dallas Texas, 2008
- MacIntyre A, Ehrenkranz NJ, Hennekens CH: Reducing infectious disease complications of healthcare practices: the need for medical student education. NEJM, 2008, submitted
- Hennekens CH, DeMets D, Bairey-Merz CN, Borzak S, Borer J: Doing more good than harm: the need for a cease fire. AJM, 2009, in press.
- Hennekens CH: Statin inducted muscle symptoms and signs: an hypothesis to reconcile randomized evidence with clinical impressions AJM, 2009, in press
Dr. Hennekens is the author/co-author of 805 publications including 591 original reports, 211 reviews and
book chapters, and 3 textbooks.
- Diplomate, National Board of Medical Examiners, 1968
- New York License, 1968-71
- Massachusetts License (33712), 1971-
- Florida License (19261)1972-78
- Diplomate, American Board of Preventive Medicine, 1976
- Fellow, American College of Preventive Medicine (FACPM), 1976
- Fellow, American College of Epidemiology (FACE), 1981
- Fellow, American College of Angiology (FACA), 1992
- Fellow, American College of Cardiology (FACC), honoris causa, 1995
- Florida License (ME 84539) 2002-
- Butcher Scholarship, University of Pennsylvania, Philadelphia, PA, 1959-1960
- New York State Regents Scholarship for Mathematics, Science and Engineering, Queens College, New York, NY, 1960-1963
- Phi Beta Kappa, Queens College, New York, NY, 1962
- Teagle Scholarship, Cornell University Medical College, New York, NY,1963-1967
- Post-Doctoral Prize Paper, Society for Epidemiologic Research, Albany, NY, 1975
- Fellow, Council on Epidemiology, American Heart Association, Dallas, TX1977
- Research Career Development Award, National Institutes of Health (HL 00286), Bethesda, MD1977-1982
- Distinguished Achievement Award, Esquire Magazine, New York, NY1988
- Keynote speaker, Argentine Society of Cardiology, Buenos Aires, Argentina1988
- Keynote speaker, German Society for Internal Medicine, Wiesbaden, Federal Republic of Germany1989
- Murray MacGregor Gardner Memorial Lecturer, Watertown, New York1989
- Alexander D. Langmuir Lecturer, EIS Conference, Centers for Disease Control, Atlanta, GA1989
- Aaron Feder Visiting Professor of Medicine, New York Hospital, Cornell Medical Center, New York, NY1990
- Raymond Kroc Visiting Professor of Medicine and Preventive Medicine, University of New Mexico School of Medicine, Albuquerque, NM, 1990
- President-Elect, Society for Epidemiologic Research, Buffalo, NY1990-1991
- Wade Hampton Frost Lecturer, American Public Health Association1991
- Samuel Berry Memorial Lecturer, Greater Boston Dental Society, Boston, MA1991
- Visiting Professor of Medicine and Social and Preventive Medicine, University of Queensland, Brisbane, Australia 1991
- President, Society for Epidemiologic Research, Minneapolis, MN1991-1992
- First University Lecturer in the Graduate School of Health Sciences, New York Medical College, Valhalla, NY1992
- James D. Bruce Memorial Award, American College of Physicians, San Diego, CA1992
- Fellow, Council on Geriatric Cardiology, Raleigh, NC1993
- Keynote Speaker, Polish Society of Cardiology, Lublin, Poland1993
- Fellow, The Royal Society of Medicine, London, England1993
- Founder Member, Society of Cardiovascular Disease in the Elderly, London, England1994
- Keynote Speaker, Symposium on Cardiology in honor of Dr. Rene Favaloro, Buenos Aires, Argentina1994
- Association of American Physicians, Philadelphia, PA1994
- VERIS Award, Henkel Corp., LaGrange, IL1995
- Lilienfeld Award, American College of Epidemiology1995
- First Robert S. Gordon Jr. Lectureship, NIH1995
- Inaugural Speaker, XXII Argentine Congress of Cardiology, Buenos Aires1995
- Schick Lecture, Morton Plant Hospital, Clearwater, FL1995
- Duncan Clark Award for Excellence in Teaching Preventive Medicine, Association of Teachers of Preventive Medicine, Washington, DC, 1996
- President-Elect, American Epidemiological Society, Minneapolis, MN1996-1997
- Vivian and Norman Weiden Lecture, The New York Cardiological Society, New York, NY1996
- Physician's Recognition Award, American Medical Association, Chicago, IL1996
- Denham Harman Lecture, American College for Advancement in Medicine, Orlando, FL1996
- James B. Herrick Lecture, American Heart Association of Metropolitan Chicago, Chicago, IL1996
- American College of Nutrition Award1996
- Lewis A. Conner Lecture, American Heart Association Annual Meeting, New Orleans, LA1996
- President, American Epidemiological Society, Minneapolis, MN1997-1998
- Roll Call of Honor, The Scientist1997
- Jan J. Kellermann Memorial Award, International Society of Heart Failure, Washington, DC1997
- Weinstein Memorial Lecture, Suburban Hospital, Bethesda, MD1997
- Ninth Annual Alvin L. Schultz Lecture and Visiting Professor at Hennepin County Medical Center, Department of Medicine, University of Minnesota, Minneapolis, Minnesota1997
- Lydia Jane Roberts Lecture, University of Chicago and Chicago Nutrition Association1997
- First Annual Awardee as Public Health Physician of the Year by the American Association of Public Health Physicians1998
- Seventeenth Annual James V. Warren Lectureship and Visiting Professor, Ohio State University, College of Medicine1998
- Queens College, Distinguished Achievers' Award, Recognition of 60th Anniversary Alumni Stars1998
- American Association for Clinical Chemistry Lectureship Awardee1999
- European Society of Cardiology, Geoffrey Rose Lecture in Primary Prevention of Cardiovascular Diseases, Barcelona, Spain1999
- Spingarn Lecture and Visiting Professor at Beth Israel Medical Center, NY,NY1999
- Senior International Aspirin Awardee, Bayer AG, Leverkusen, Germany1999
- Strathmore’s Who’s Who, V.I.P. Member2003
- Peter Kuo Lecture, Robert Wood Johnson Medical School, New Brunswick, New Jersey2003
- International Health Professional of the Year, Nominee, Cambridge, England2004
- Keynote Speaker, Whitfield-Murray Medical Society, Dalton, GA2005
- Visiting Professor, University of Arkansas for Medical Sciences and Cewntral Arkansas Veteran’s
- Healthcare System, Division of Cardiovascular Medicine, Little Rock, Arkansas2006
- Invitted Speaker, Puerto Rican Society of Cardiology, San Juan, Puerto Rico2006
- Dean’s Club, Weill-Cornell Medical College2006
- Doctor of the Decade from Science Watch based on being the 3rd most widely cited medical researcher in the world (5 of the top 20 were former fellows and/or trainees)2006
- Visiting Scholar, Queens College, Queens, NY2007
- Hall of Fame, American Association of Clinical Chemistry, 2007
 |